CLINICAL_TRIALS
research
· 2017-10-12
Clinical Trial Update: Botulinum Toxin A in the Treatment of Hemifacial Spasm [NA]
Summary
This entry reports on a Tongji University-sponsored clinical trial evaluating botulinum toxin type A for hemifacial spasm; the trial status is currently unknown…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tongji University | Conditions: Hemifacial Spasm | NA | Status: UNKNOWN